// App-Quantinova.ai

3547 : CEBPD induces apoptosis through autophagy in metformin-treated HCC

Researchers

Presenter

  • I P. Lin

Principal Investigators

  • N/A

Medical Centers

  • Institute of Bioinformatics and Biosignal Transduction, NCKU, Tainan, Taiwan.

Locations

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Type 2 diabetes mellitus

  • Solid malignancies

  • Diabetes

Biomarkers

  • 1A/1B-light chain 3

  • Cyclin-dependent kinase inhibitor 1B

  • CCAAT enhancer binding protein delta

Drug/Treatment

  • Metformin Hydrochloride

  • ATG3

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A